What is the current market size?

The global Allergen Extract market size was valued at USD 1.2 billion in 2023, driven by demand for immunotherapy treatments and diagnostic applications.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, fueled by rising allergy prevalence and advancements in biotechnology.

What are the key drivers of market growth?

Key drivers include increasing incidence of respiratory and food allergies, growing adoption of sublingual immunotherapy, and expansion of diagnostic testing services.

What challenges does the market face?

Challenges include high production costs, regulatory compliance complexities, and limited awareness in emerging economies about allergen-specific treatments.

Which regions lead the market?

North America dominates the market due to advanced healthcare infrastructure, followed by Europe, while Asia-Pacific shows high growth potential due to urbanization.

Who are the top companies?

Leading players include Stallergenes Greer, ALK-Abelló, Allergy Therapeutics, and Merck KGaA, leveraging product innovation and strategic partnerships.

What future opportunities exist?

Future opportunities lie in personalized allergen profiling, expansion of combination therapies, and emerging markets adopting precision medicine approaches.

How does technology impact the market?

Automation in allergen extraction, AI-driven allergy diagnostics, and biotech advancements in recombinant allergens enhance product efficacy and production efficiency.

What is the regulatory landscape?

Regulations vary globally, with the FDA (US) and EMA (EU) enforcing strict quality standards, while emerging markets adopt evolving guidelines to ensure product safety.

What role does diagnostics play?

Diagnostic testing drives market growth by enabling early allergy detection, fostering demand for targeted immunotherapy and customized treatment plans.

Allergen Extract Industry Trends & Competitive Analysis 2033

Allergen Extract by Application (Hospital, Clinic), by Types (Tablets, Injectable), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Allergen Extract Market Size | CAGR 7.5 Forecast 2033

Allergen Extract Industry Trends & Competitive Analysis 2033

Allergen Extract by Application (Hospital, Clinic), by Types (Tablets, Injectable), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Allergen Extract Market Overview

The Allergen Extract market encompasses products used for diagnosing and treating allergic conditions, including immunotherapy and diagnostic testing. As allergies and asthma prevalence rise globally, the Allergen Extract market size is projected to expand significantly, driven by advancements in biotechnology and regulatory tailwinds. The industry is witnessing robust growth outlook and market forecast, with stakeholders prioritizing industry expansion through innovation and regional diversification. This report analyzes the market’s trajectory from 2021 to 2033, focusing on key trends shaping its evolution.

Loading chart…

The Allergen Extract market is forecasted to grow at a CAGR of ~7.3% from 2026 to 2033, with the market size expected to exceed $8.5 billion by 2033. Key drivers include technological shifts toward recombinant allergen production, regulatory frameworks promoting precision medicine, and consumer behavior trends favoring personalized immunotherapy. North America remains the largest region, while Asia-Pacific is the fastest-growing, fueled by rising healthcare infrastructure investments and allergy awareness. Strategic collaborations and R&D investments are intensifying competitive intensity, particularly in synthetic allergen development, to meet the rising demand for safer, more effective treatments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Stallergenes S.A.; ALK-Abelló A/S; Bayer AG; Thermo Fisher Scientific Inc.; Aimmune Therapeutics, Inc. (Nestlé Health Science); Sanofi; Allergy Therapeutics plc; DPC Biologics; Eurofins Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Allergen Extract market is gaining traction due to rising prevalence of autoimmune and allergic diseases, particularly in urbanized regions, which is fueling demand for diagnostic and therapeutic applications. Technological advancements in allergen-specific immunotherapy (AIT) are further driving adoption, supported by a favorable regulatory environment in North America and Europe.

Expansion of the biopharmaceutical sector and increased R&D investments in precision medicine are accelerating the growth forecast for the Allergen Extract market. The development of next-generation diagnostic tools, such as multiplex immunoassays, is enhancing the accuracy of allergen identification, thereby broadening market reach.

Restraints2 items

High production costs associated with allergen extraction and purification processes, particularly for rare or complex allergens, are limiting scalability. These expenses are exacerbated by stringent quality control protocols mandated by regulatory bodies.

The emergence of synthetic allergen alternatives and in vitro diagnostic methods is reducing reliance on traditional Allergen Extract market products. Competitors leveraging CRISPR-based technologies for allergen mimicry are gaining market share, eroding growth potential.

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America present untapped potential as rising healthcare awareness and improving diagnostic infrastructure drive demand for Allergen Extract market solutions. Strategic partnerships with local distributors could unlock these high-growth regions.

Innovation in recombinant allergen production offers a sustainable pathway to overcome supply constraints from natural sources. This technology also enables the development of hypoallergenic variants, catering to niche therapeutic segments and boosting the Allergen Extract market size.

Challenges2 items

Regulatory fragmentation across regions—such as divergent FDA, EMA, and WHO guidelines—creates compliance complexities for manufacturers, increasing time-to-market and operational costs for Allergen Extract market players.

Supply chain vulnerabilities, including reliance on geographically concentrated sources for raw materials like insect or pollen allergens, pose risks from climate disruptions and geopolitical instability, threatening consistent product availability.

Market Segmentation

Loading chart…

Application is a critical axis in Allergen Extract segmentation, reflecting how extract-based solutions are utilized across clinical and research domains. The diagnostic testing segment dominates, driven by rising allergy prevalence and demand for accurate, rapid diagnostics. Diagnostic applications, including skin prick tests and serum-based assays, account for over 60% of market activity due to their role in identifying specific allergen sensitivities. Immunotherapy applications, such as subcutaneous or sublingual treatments, represent a growing segment, fueled by advancements in allergen-specific therapies. Research applications, though smaller in revenue share, are experiencing accelerated growth due to innovations in bioinformatics and personalized medicine. These applications collectively define the market taxonomy by shaping demand patterns and regulatory priorities.

Types of allergen extracts are categorized into natural and synthetic derivatives, each with distinct contributions to market dynamics. Natural extracts, sourced from environmental allergens (e.g., pollen, dust mites) or food allergens (e.g., peanuts, dairy), constitute ~85% of the market due to their clinical specificity and regulatory approval for diagnostics and immunotherapy. Their dominance is sustained by existing infrastructure for purification and standardization. Synthetic extracts, including recombinant allergens and chemically synthesized peptides, are emerging as a ~15% segment, driven by demand for consistent, contamination-free products and advancements in biotechnology. The synthetic category is particularly influential in research settings, where tailored allergen variants are required for studying molecular mechanisms. This duality in Allergen Extract segmentation reflects evolving technological capabilities and unmet clinical needs.

Allergen Extract Segmentation Breakdown6 items

Application

Hospital

Clinic

Types

Tablets

Injectable

Regional Insights

Loading chart…

North America dominates the Allergen Extract market with a 40% share, driven by advanced healthcare infrastructure, stringent regulatory policies, and high adoption of diagnostic technologies. The region benefits from robust R&D investments and a mature ecosystem for biopharmaceuticals.

Europe follows with a 30% share, supported by aging demographics, strong public healthcare funding, and harmonized regulatory frameworks. Increasing prevalence of food allergies and investments in precision medicine further fuel the regional forecast for sustained growth.

Asia Pacific leads in growth, projected to expand at a CAGR of 8.5% through 2030. Key drivers include rising healthcare investments, urbanization, and growing awareness of allergen management. Countries like India and China are prioritizing infrastructure upgrades and digital health initiatives to meet rising demand.

Latin America and the Middle East & Africa represent emerging markets, with shares of 10% and 5%, respectively. In Latin America, policy reforms and expanding private-sector partnerships are critical to Allergen Extract market growth. Meanwhile, infrastructure development and rising disposable incomes in the Middle East & Africa signal untapped potential.

Competitive Landscape

The Allergen Extract key players market remains moderately consolidated, with a mix of global pharmaceutical firms and specialized biotech companies. Major participants leverage differentiated pricing strategies, regulatory approvals, and distribution networks to secure market position. While global players like Merck and Bayer AG dominate standardized product categories, regional firms such as Stallergenes S.A. and DPC Biologics focus on niche allergen profiles and localized demand. Competitive advantages often stem from proprietary extraction technologies, partnerships with diagnostic firms, and compliance with international certification standards. Pricing pressure intensifies in commoditized segments, while innovation in sublingual immunotherapy formulations drives differentiation.

Strategic priorities include M&A for IP consolidation, R&D for next-generation allergen profiling, and local manufacturing to mitigate supply chain risks. Companies differentiate via advanced analytics platforms for allergen customization or cost-efficient production methods. A critical challenge is rising compliance costs due to evolving regulatory frameworks, particularly in EU and U.S. markets. Firms also balance margin pressures with investments in sustainability initiatives and vertical integration to stabilize raw material sourcing.

Merck: Innovation pipeline for sublingual immunotherapy

Stallergenes S.A.: Regional expansion in emerging markets

ALK-Abelló A/S: Vertical integration in raw material sourcing

Bayer AG: OEM tie-ups for diagnostic-allergen bundles

Thermo Fisher Scientific Inc.: Premium pricing for advanced extraction tech

Aimmune Therapeutics, Inc.: Customization for peanut allergy treatments

Key Allergen Extract Companies10 items

Merck

Stallergenes S.A.

ALK-Abelló A/S

Bayer AG

Thermo Fisher Scientific Inc.

Aimmune Therapeutics, Inc. (Nestlé Health Science)

Sanofi

Allergy Therapeutics plc

DPC Biologics

Eurofins Scientific

Market Ecosystem

The Allergen Extract ecosystem spans upstream biological sourcing, midstream processing, and downstream diagnostic/diagnostic therapy applications. Value is generated through standardized extraction methodologies, regulatory compliance, and integration into allergy testing and immunotherapy protocols. The ecosystem is shaped by input constraints such as raw material availability and adherence to clinical validation requirements.

Raw material suppliers – provide biological sources (pollen, mold, animal dander) from controlled environments

Extract producers – process and standardize allergens via fractionation and preservation techniques

Testing laboratories – perform immunoassay validation and potency analysis for regulatory compliance

Diagnostic kit manufacturers – integrate allergen extracts into lateral flow or ELISA-based testing platforms

Distributors – manage supply chain logistics and quality assurance for healthcare and pharmaceutical clients

Healthcare providers – deploy extracts in allergy diagnosis and subcutaneous/sublingual immunotherapy

Regulatory bodies – enforce standards for allergen potency, labeling, and cross-reactivity disclosure

Control points in the value chain analysis include regulatory gatekeepers and testing laboratories, which dictate market entry timelines and product specifications. Dependency risks arise from seasonal raw material variability and stringent validation protocols. Switching costs for end users are elevated due to certified supplier contracts and interoperability requirements with existing diagnostic systems. Regional ecosystems diverge in regulatory frameworks, with the EU emphasizing batch-to-batch consistency and the US prioritizing IVD classification pathways.

Recent Industry Insights

The Allergen Extract industry trends over the past 18 months reflect a dynamic shift driven by innovation, regulatory updates, and evolving market demands. Strategic partnerships have accelerated, with companies like AllergyBio collaborating with pharmaceutical giants to co-develop precision allergy therapies. In Mergers & acquisitions, firms such as ALK and Stallergenes Greer expanded their portfolios by acquiring niche biotech startups specializing in molecular allergen profiling. Product/technology launches highlight advancements like AI-driven allergen detection kits and next-gen sublingual immunotherapy (SLIT) formulations, enhancing treatment accessibility. Regulatory changes in the EU and US have tightened quality standards for allergen extracts, pushing manufacturers to adopt GMP-compliant production. Consumer trends emphasize personalized medicine, with demand surging for customized allergy testing and treatment plans. Funding rounds totaling $150M in 2023 supported startups leveraging CRISPR-based allergen modification, signaling a pivot toward biotechnology-driven solutions. As the industry prioritizes precision, scalability, and compliance, stakeholders are positioning for a 6.2% CAGR through 2030.

Analyst Overview

The Allergen Extract market demonstrates strong attractiveness, driven by rising prevalence of allergies and immunotherapies globally. Market expansion is further supported by advancements in diagnostic accuracy and personalized treatment solutions. Competitive intensity remains moderate, with key players focusing on strategic partnerships and R&D investments to differentiate offerings. The long-term outlook for the Allergen Extract market is optimistic, underpinned by sustained demand in both developed and emerging economies.

Key Insights3 items

Innovation landscape is evolving with biotechnology-enabled precision extraction methods enhancing product efficacy.

Demand–supply balance remains stable, though raw material volatility poses intermittent challenges.

Key risk factors include regulatory shifts, stringent quality standards, and supply chain disruptions from climate-related events.

Stakeholders must prioritize agility in sourcing and compliance frameworks to mitigate risks while capitalizing on the Allergen Extract market outlook of sustained growth.

12 items

1. Executive Summary

2. Allergen Extract Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Allergen Extract Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Allergen Extract Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Allergen Extract Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Allergen Extract Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Allergen Extract Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Allergen Extract Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Allergen Extract Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Allergen Extract Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Allergen Extract Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Allergen Extract Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Allergen Extract Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Allergen Extract Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Allergen Extract Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Allergen Extract Market Competition by Key Manufacturers

9.1. Global Allergen Extract Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Allergen Extract: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Merck

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Stallergenes S.A.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ALK-Abelló A/S

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bayer AG

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Thermo Fisher Scientific Inc.

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Aimmune Therapeutics, Inc. (Nestlé Health Science)

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Sanofi

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Allergy Therapeutics plc

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. DPC Biologics

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Eurofins Scientific

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Allergen Extract Market

Figure 4: Global Allergen Extract Market: Drivers

Figure 5: Global Allergen Extract Market: Challenges

Figure 6: Global Allergen Extract Market: Trends

Figure 7: Global Allergen Extract Market: Opportunity

Figure 8: Global Allergen Extract Market: Restraint

Figure 9: Global Allergen Extract Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Allergen Extract Market Value (USD Million) By Region

Figure 19: Global Allergen Extract Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Allergen Extract Market Value (USD Million) By Region

Figure 27: Global Allergen Extract Market Share (%) By: Regions (2032)

Figure 28: Global Allergen Extract Market Volume (K) By Region

Figure 29: Global Allergen Extract Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Allergen Extract Market Value (USD Million) By Region

Figure 37: Global Allergen Extract Market Share (%) By: Regions (2032)

Figure 38: Global Allergen Extract Market Volume (K) By Region

Figure 39: Global Allergen Extract Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Allergen Extract Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Allergen Extract Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Allergen Extract Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Allergen Extract Market Value (USD Million) By Region

Table 14: Global Allergen Extract Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Allergen Extract Market Volume (K) By Region

Table 31: Global Allergen Extract Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Allergen Extract Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Allergen Extract Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Allergen Extract Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Merck Basic Information And Sales Area

Table 52: Merck. Products Portfolio

Table 53: Stallergenes S.A. Basic Information And Sales Area

Table 54: Stallergenes S.A.. Products Portfolio

Table 55: ALK-Abelló A/S Basic Information And Sales Area

Table 56: ALK-Abelló A/S. Products Portfolio

Table 57: Bayer AG Basic Information And Sales Area

Table 58: Bayer AG. Products Portfolio

Table 59: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 60: Thermo Fisher Scientific Inc.. Products Portfolio

Table 61: Aimmune Therapeutics, Inc. (Nestlé Health Science) Basic Information And Sales Area

Table 62: Aimmune Therapeutics, Inc. (Nestlé Health Science). Products Portfolio

Table 63: Sanofi Basic Information And Sales Area

Table 64: Sanofi. Products Portfolio

Table 65: Allergy Therapeutics plc Basic Information And Sales Area

Table 66: Allergy Therapeutics plc. Products Portfolio

Table 67: DPC Biologics Basic Information And Sales Area

Table 68: DPC Biologics. Products Portfolio

Table 69: Eurofins Scientific Basic Information And Sales Area

Table 70: Eurofins Scientific. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Allergen Extract Market Value (USD Million) By Region

Table 80: Global Allergen Extract Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Allergen Extract Market Volume (K) By Region

Table 97: Global Allergen Extract Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Allergen Extract Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.14 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Stallergenes S.A.; ALK-Abelló A/S; Bayer AG; Thermo Fisher Scientific Inc.; Aimmune Therapeutics, Inc. (Nestlé Health Science); Sanofi; Allergy Therapeutics plc; DPC Biologics; Eurofins Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options